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Background: The mechanisms underlying autoimmune thyroid disease (AITD) remain elusive. Identification
of such mechanisms would reveal novel and/or better therapeutic targets. Here, we use integrated analysis
of miRNAs and mRNAs expression profiling to identify potential therapeutic targets involved in the mecha-
nisms underlying AITD.
Methods: miRNA and mRNA from twenty fresh-frozen thyroid tissues (15 from AITD patients and 5 from
healthy controls) were subjected to next-generation sequencing. An anti-correlated method revealed poten-
tial pathways and disease targets, including proteins involved in the formation of primary cilia. Thus, we
examined the distribution and length of primary cilia in thyroid tissues from AITD and controls using immu-
nofluorescence and scanning electron microscopy, and parsed cilia formation in thyroid cell lines in response
to inflammatory stimuli in the presence of miRNA mimics.
Findings: We found that the expression of miR-21-5p, miR-146b-3p, miR-5571-3p and miR-6503-3p was
anti-correlated with Enolase 4 (ENO4), in-turned planar cell polarity protein (INTU), kinesin family member
27 (KIF27), parkin co-regulated (PACRG) and serine/threonine kinase 36 (STK36) genes. Functional classifica-
tion of these miRNA/mRNAs revealed that their differential expression was associated with cilia organization.
We demonstrated that the number and length of primary cilia in thyroid tissues was significantly lower in
AITD than in control (frequency of follicular ciliated cells in controls = 67.54% vs a mean of 22.74% and 21.61%
in HT and GD respectively p = 0.0001, by one-way ANOVA test). In addition, pro-inflammatory cytokines
(IFNg and TNFa) and specific miRNA mimics for the newly identified target genes affected cilia appearance
in thyroid cell lines.
Interpretation: Integrated miRNA/gene expression analysis has identified abnormal ciliogenesis as a novel
susceptibility pathway that is involved in the pathogenesis of AITD. These results reflect that ciliogenesis
plays a relevant role in AITD, and opens research pathways to design therapeutic targets in AITD.
Funding: Instituto de Salud Carlos III, Comunidad de Madrid, Grupo Espa~nol de Tumores Neuroendocrinos y
Endocrinos, Ministerio de Economía y Empresa and FEDER.
© 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)Keywords:
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Evidence before this study
The mechanisms underlying autoimmune thyroid disease (AITD)
remain elusive. The synergy between susceptibility genes and envi-
ronmental stimulation, together with epigenetic modulation, denote
the multifactorial interplay involved in the pathogenesis of AITD.
MicroRNAs (miRNA), which are small noncoding RNA that regulate
gene expression at a posttranscriptional level, have also been impli-
cated in the pathogenesis of AITD. Understanding the regulatory role
of these miRNAs could led to identify potential susceptibility path-
ways, diagnostic biomarkers and therapeutic targets of the disease.
The use of integrative analysis of omics data such as miRNAs and
mRNAs expression profiling could help to identify novel pathways
and biomarkers, and reveal novel and/or better therapeutic targets to
treat AITD.
Added value of this study
The major findings of our study include the following: (i) Expres-
sion of miR-21-5p, miR-146b-3p, miR-5571-3p and miR-6503-3p are
up-regulated in AITD and anti-correlated with Enolase 4 (ENO4), in-
turned planar cell polarity protein (INTU), kinesin family member 27
(KIF27), parkin co-regulated (PACRG) and serine/threonine kinase 36
(STK36) genes. (ii) The functional classification of these miRNA/
mRNAs are associated with cilia organization. (iii) The percentage
and length of primary cilia in thyroid tissues is lower in AITD com-
pared to controls. (iv) Pro-inflammatory cytokines (IFNg and TNFa)
affect cilia appearance in thyroid cell lines. (v) Treatment of thyro-
cytes with cytokines and specific miRNA mimics repress the expres-
sion of cilia-related genes for the newly identified target genes, and
display less and shorter cilia.
Implication of all available evidence
We have identified a molecular signature that regulates primary
cilia as a novel susceptibility pathway that controls the pathogenesis
of AITD. These results reflect that ciliogenesis plays a relevant role in
AITD, and opens novel research pathways to protect against the dis-
ease, including therapeutic targeting of miRNAs.
Introduction
Autoimmune thyroid disorders (AITD)  Graves’ disease (GD) and
Hashimoto’s thyroiditis (HT)  result from a dysregulation of the
immune system directed against the thyroid gland. Both diseases fea-
ture circulating thyroid antibodies and infiltration of autoreactive
lymphocytes in the thyroid gland, and sometimes the orbit. HT is a
predominantly cellular autoimmune disease with prominent inflam-
matory infiltration, leading to destruction of the thyroid gland. Con-
versely, GD emerges as an essentially humoral autoimmune
response, featuring autoantibodies directed against the thyrotropin
receptor (TSHR-Ab). These antibodies stimulate the growth and func-
tion of thyroid follicular cells and lead to the development of goiter
and hyperthyroidism [13]. A major occurrence in GD disease is
Graves’ ophthalmopathy (GO), which shares cellular and humoral
traits and is arguably the most common extra-thyroid manifestation
of AITD [4]. The specific mechanisms underlying the pathogenesis of
AITD have remained elusive, but seem to include the combination of
specific susceptibility genes together with environmental stimula-
tion, causing a breakdown of CD4+ T cell-dependent self-tolerance,
and the subsequent development of autoimmune diseases. Different
studies have associated the presence of other autoimmune disorders
in patients with AITD, which underlines the importance of a common
immunopathogenesis of these disorders [5]. In this context, thesynergy between susceptibility genes and environmental stimulation
is also accompanied by epigenetic modulation, e.g. DNA demethyla-
tion, histone modification and abnormalities in the expression of
RNA interference, including microRNAs [6,7]. MicroRNAs (miRNAs)
are small non-protein-coding RNA molecules of 22 nucleotides that
interact with specific RNA target(s) in a sequence-dependent manner,
regulating gene expression at a post-transcriptional level [8]. As such,
they control a plethora of biological phenomena, including immune
activation, apoptosis, differentiation and development, proliferation
and metabolism. This role makes miRNA attractive candidates as dis-
ease biomarkers or even therapeutic devices.
In the specific setting of AITD, transcriptomic data from different
sources, including miRNA and mRNA, have improved our under-
standing on the complex gene regulatory networks involved in the
pathophysiology of disease [9,10]. Specifically, abnormal miRNA
expression underlies the differentiation and activation of immune
cells (reviewed in [7]). In line with these findings, we have recently
identified a collection of deregulated miRNAs in thyroid tissue and
serum of AITD patients using Next Generation Sequencing (NGS),
which constitutes the backbone of a novel 5-miRNA signature useful
as a AITD risk biomarker [11]. Thus, modeling context-specific miR-
NAmRNA networks has the potential to identify mechanisms that
can cause AITD. In this regard, an integrative analysis of miRNA and
mRNA in GD identified a clear association between the retinoic acid
pathway and the development of GD [12]. Herein, we used NGS tech-
niques to develop an integrative analysis of the gene expression pro-
filing of miRNAs and mRNAs, from thyroid tissue to identify and
characterize novel molecular pathways of the disease. The negative
correlation analysis of the differentially expressed miRNAs and
mRNAs led to the identification of key signaling pathways altered in
AITD. Interestingly, most of these pathways control the formation of
primary cilia. Indeed, primary cilia in the thyroid gland emerge from
the apex of follicular cells of different mammals [13]. In humans, cilia
are usually located in a central position on the thyrocyte surface [14].
Although the role of primary cilia in thyroid tissue remains obscure,
some authors have suggested that they could be involved in thyro-
globulin secretion and/or control mechanosensory events [1315].
Recently, defective ciliogenesis have been associated with thyoid
pathology, however no molecular mechanisms were identified [16].
In this study, we identify a molecular mechanism that could con-
trol primary cilia formation as an important mechanism underlying
AITD. Furthermore, the effect of pro-inflammatory cytokines and
miRNA targeting in primary cilia formation in thyroid cells suggest
the potential usefulness of this pathway as a novel therapeutic ave-
nue to treat these diseases.
Materials and methods
Human samples
Thyroid tissue samples were collected from patients with AITD
who underwent thyroidectomy at the Surgical Department of the
Hospital Universitario de la Princesa. As controls, normal thyroid
parenchyma samples adjacent to other thyroid lesions were col-
lected. All thyroid tissues were reviewed by an experienced patholo-
gist, and diagnosis was reconfirmed by an endocrinologist, based on
well-established clinical, laboratory and histological criteria [2].
Serum free thyroxine 4 (FT4), thyroid stimulating hormone (TSH),
and levels of antibodies against thyroglobulin (Tg), thyroperoxidase
(TPO) and thyrotropin receptor (TR) were measured as previously
described at the time of thyroid surgery [17]. Thyroid glands were
fixed in 10% neutral buffered formalin, embedded in paraffin, sec-
tioned (45 mm thick slices), and mounted on FLEX IHC Microscope
Slides (Dako) for immunofluorescence. Sections were also stained
with hematoxylin-eosin for histological diagnosis. Clinical data are
summarized in Tables 1 and 2.
Table 1
Clinical features of patients with autoimmune thyroid disease (AITD) from whom NGS was performed.
AITD HT GD GO p-value
n 5 4 5
Gender (F/M) 5/0 4/0 5/0
Age (year) 54.2 § 12.3 47.2 § 15.4 40.6 § 11.6 0.3024 (one way ANOVA)
TSH mU/mL 1.7 (1.0415.22) 2.8 (0.487.6) 2.5 (0.521.72) 0.9463 (KruskalWallis test)
T4 ng/dL 1.1 (1.11.12) 0.86 (0.811.5) 1.19 (0.671.27) 0.9452 (KruskalWallis test)
Tg-Ab UI/mL 342 (133.8446.8)   
TPO-Ab UI/mL 228 (52.51577)   
TSHR-Ab U/L  3.655 (1.4623.05) 4.37 (1.5516.63) > 0.9999 (MannWhitney test)
Values show number for categorical values and median (interquartile intervals 2575) for continuous variables.
HT = Hashimoto’s thyroiditis; GD = Graves’ disease. F/M = female/male; TSH, thyrotropin (Normal range = 0.274.20); T4,
thyroxine (Normal range = 0.931.7); Tg-Ab, anti-thyroglobulin antibody (Negative <344); TPO-Ab, anti-thyroid peroxi-
dase antibody (Negative <100); TSHR-Ab, anti-thyrotropin receptor antibody (Negative <0.7).
Table 2
Clinical features of patients with autoimmune thyroid disease (AITD) from whom RT-PCR was performed.
AITD HT GD GO p-value
n 13 13 13
Gender (F/M) 12/1 12/1 12/1
Age (year) 49.7 § 15.9 43.2 § 16.4 38.9 § 9.9 0.1704 (one way ANOVA)
TSH mU/mL 1.97 (0.842.72) 0.3 (0.011.38) 0.4 (0.011.76) 0.0527 (KruskalWallis test)
T4 ng/dL 1.22 (1.041.41) 1.49 (1.022.27) 1.12 (0.961.23) 0.3692 (KruskalWallis test)
Tg-Ab UI/mL 334 (180412) 360 (3441134) 643.5 (201483) 0.4569 (KruskalWallis test)
TPO-Ab UI/mL 306 (150724.5) 125.5 (61.62235) 354 (101812) 0.6506 (KruskalWallis test)
TSHR-Ab U/L  3.8 (1.8228.9) 2.4 (1.45.63) 0.4313 (MannWhitney test)
Values show number for categorical values and median (interquartile intervals 2575) for continuous variables.
HT = Hashimoto’s thyroiditis; GD = Graves’ disease; GO=Graves'Ophthalmopathy. F/M = female/male; TSH, thyrotro-
pin (Normal range = 0.274.20); T4, thyroxine (Normal range = 0.931.7); Tg-Ab, anti-thyroglobulin antibody (Nega-
tive <344); TPO-Ab, anti-thyroid peroxidase antibody (Negative <100); TSHR-Ab, anti-thyrotropin receptor antibody
(Negative <0.7).
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out in the Declaration of Helsinki under a protocol approved by the
Internal Ethical Review Committee of the Hospital de la Princesa
(Committee Register Number: 2796). All subjects gave written
informed consent in accordance with the Declaration of Helsinki.
Tissue miRNA and mRNA isolation
Thyroid tissue samples were immediately snap-frozen in liquid
nitrogen cooled isopentane and transferred to a 80 °C freezer. RNA
was isolated from 50 fresh-frozen thyroid tissues (13 with HT, 13 with
GD, 13 with GO and 11 controls): 19 samples were used for miRNA
and mRNA NGS, 36 samples to validate miRNAs and all 50 for qRT-PCR
mRNA validation test. Total RNA was isolated using miRNeasy Mini Kit
(Qiagen). The quality and quantity of RNA and microRNA were
assessed in a 2100 Bioanalyzer using a RNA 6000 Nano kit and Small
RNA kit (Agilent Technologies). Only samples with RIN>7 were used.
Next generation sequencing of mRNA and microRNA
NGS procedure was performed as previously described [11].
Briefly, 1 mg of RNA was used for NGS. Integrity and quality of the
ribosomal depleted RNA was checked with Agilent Bioanalyzer 2100
(Agilent Technologies). RNA sequencing was carried out by Sistemas
Genomicos (https://www.sistemasgenomicos.com/web_sg/) with the
Next Generation Sequence (NGS) platform using the Illumina HiSeq
2000 sequencing instrument (Illumina). Ribosomal-depleted samples
were used to generate whole transcriptome libraries. Amplified
cDNA quality was analyzed with the Bioanalyzer 2100 DNA 1000 kit
(Agilent Technologies) and quantified using the Qubit 2.0 Fluorome-
ter (Invitrogen). The bioinformatic analysis of NGS and raw data
availability is described in Supplementary Materials and Methods.
Quantitative real-time RT-PCR for miRNAs
First-strand cDNA was generated using cDNA synthesis kit and
subsequent quantitative Real Time PCR (q-RT-PCR) was performedby triplicate using miRCURY LNATM Universal RT microRNA PCR and
SYBR Green (both from Qiagen) with the CFX384 Touch Real-Time
PCR Detection System (Bio-Rad). Expression of miRNAs was per-
formed using microRNA LNATM PCR primer sets for hsa-miR-21-5p,
hsa-miR-146b-3p, hsa-miR-5571-3p, and hsa-miR-6503-3p. Simulta-
neously, 5S, U6, SNORD48 and RNU1A1 were used as candidate refer-
ence genes (Qiagen). Data were normalized using the geometric
mean Ct of the best gene combination generated by the NormFinder
algorithm [18] (RNU1A1 and SNORD48) and as previously reported
[11]. Relative expression was determined using the log base 2 values
of the difference Cts between miRNAs and the geometric mean of the
selected housekeeping genes.
Quantitative real-time RT-PCR for gene expression
To validate the different expression levels of the mRNA genes
determined by NGS, qPCR primers were selectively designed for
5 mRNA genes (STK36, INTU, ENO4, PACRG and KIF27  Supplemen-
tary Table 1a for the sequence of primers) that were found to be dif-
ferentially expressed in the discovery screen. b-Actin, GAPDH and
HPRT were used as reference genes. RNA from each sample was
reverse transcribed for cDNA synthesis using high-capacity cDNA
reverse transcription kit with a ribonuclease inhibitor (Thermo-
Fisher), following the manufacturer’s instructions. cDNAs were
amplified using Power SYBR Green PCR master mix (ThermoFisher
Scientific). Relative expression was determined using the log base 2
values of the difference Cts between mRNAs and the geometric mean
of b-Actin and GAPDH (selected reference genes by NormFinder [18],
Supplementary Table 1b).
Immunofluorescence staining
Serial sections from 20 paraffin embedded thyroid tissues (5 con-
trols, 5 nodular hyperplasia (NH), 5 HT and 5 GD) were placed in an
oven at 65 °C for 30 min. Thyroid-sections were then deparaffinised in
xylene and rehydrated through graded alcohols. Antigen retrieval was
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solution high pH (Dako). Non-specific binding was blocked using 5%
bovine serum albumin and 10% normal goat serum for 30 min.
Cells were cultured on round coverslips in 6-well plates. After
incubation under the indicated conditions, cells were washed with
1£ PBS and fixed with 4% paraformaldehyde in PBS for 15 min, and
then permeabilized with 0.1% Triton X-100 in PBS for 10 min at room
temperature. Permeabilized cells were blocked with 5% bovine serum
albumin and 10% normal goat serum in PBS for 15 min at room tem-
perature. Thereafter, tissue sections and cultured cells were incu-
bated with primary antibodies. Primary antibodies were incubated
over night at 4 ᵒC. On the following day, slides were washed three
times with PBS and incubated 1 h with secondary antibody. Primary
antibodies against acetylated alpha-tubulin (Sigma-Aldrich) and ADP
ribosylation factor like GTPase 13B (Arl13B) (Proteintech) were used.
Alexa 488 labeled goat anti-mouse and Alexa 568 labeled goat anti-
rabbit (Invitrogen) were used as secondary antibodies. 40,6-diami-
dino-2-phenylindole (DAPI) was used for nuclei counterstained.
Stacks of 57 mm-thick were observed using a Leica Sp5 for cilia
quantification. For high resolution images, sections were acquired in
STED mode in a Leica SP8 confocal microscope.Morphometric analysis
The frequency of cilia in a total of 20 thyroid sections was esti-
mated manually by analyzing Z-stacked images captured in confocal
microscope. Low and higher magnification images were analyzed by
two independent observers in a blinded way. The frequency of follicu-
lar ciliated cells was estimated by analyzing the relative number of
cilia protruding from the apical surface of the epithelium vs. the num-
ber of nuclei in adequately oriented sections of those thyroid follicles
as previously reported [13]. A total of 5796 nuclei in control samples,
7902 in HT, 6492 in GD and 1123 in NH in 41, 70, 54 and 24 thyroid tis-
sue fields was analyzed, respectively. Primary cilia length was mea-
sured using the ROI measurement tool of Image J Software (NIH) in a
total of 3863 cilia in controls, 1886 in HT, 1299 in GD and 863 in NH.Scanning electron microscopy
For scanning electron microscopy (SEM) studies, two control and 4
AITD (2 HT and 2 GD) thyroid tissue samples were fixed in 2% glutaral-
dehyde and 2% paraformaldehyde in phosphate buffer. All images
were acquired with a high resolution FEI Verios 460 Field Emission
SEM in high vacuum conditions (10E-610E-7 mbar) with 2 kV beam
acceleration voltage and 1 kV beam deceleration (sample bias), result-
ing in 1 kV incidence voltage. The specimens were imaged directly on
glass substrates without any metal coating after being dehydrated in a
graded alcohol series and dried thoroughly by evaporation of hexame-
thyldisilazane (HMDS, Sigma-Aldrich). Other imaging parameters
were: current, 13 pA; working distance, 34 mm; scanning mode, and
integration of 100 frames with 100 nS dwell time.Cell preparation
Human cell lines Nthy-ori 3-1 (kindly provided by Dr. Pilar Santis-
teban, Instituto de Investigaciones Biomedicas ‘Alberto Sols’, Spain)
were cultured in RPMI 1640 with GlutaMAX medium supplemented
with 10% FBS (Hyclone), 1% of penicillin/streptomycin (Gibco) and
10 mU/ml of thyroid stimulated hormone (TSH, Sigma-Aldrich). For
experiments, cells were seeded at confluence and were grown in
media without serum for 48 h to induce cell cycle arrest and promote
primary cilia assembly as previously described [13,19]. These cells
were incubated at the same time with or without proinflammatory
cytokines, including 1000 U/ml IFN-g (R&D systems) and 800 mU/ml
TNF-a (R&D systems), as previously described [20]. All experiments
were performed in triplicate wells for each condition, and three inde-
pendent experiments were carried out.miRNA mimics transfection
Nthy-ori 3-1 cell lines were seeded in 6-well plates 1824 h prior
to transfection. Following manufacturer’s instructions, media were
replaced with antibiotics-free media 612 h before transfection. Nega-
tive control miRCURY LNA miRNA mimic 50FAM (339173
YM00479902-ADB, Qiagen) and a pool of hsa-miR-146b-3p, hsa-miR-
21-5p and hsa-miR-6503-3p miRNA mimics (339176 YM00473138-
ADB, YM00473093-ADB and YM00471117-ADB respectively, Qiagen)
were transfected using Lipofectamine RNAiMAX (Invitrogen), accord-
ing to the manufacturer’s protocol. Twenty-four hours later, media
were replaced with the same conditions, as previously described in
cell preparation methods.
Western blot analysis
Cells and tissues were washed twice with PBS and lysed in RIPA
lysis buffer (Sigma-Aldrich) supplemented with HaltTM Protease and
Phosphatase Inhibitor Cocktail (Thermo-Fisher Scientific). Lysates
were sonicated and protein concentrations were measured using a
PierceTM BCA Protein Assay Kit (Thermo-Fisher Scientific). Samples
were resolved in a 8% SDS-PAGE and transferred to nitrocellulose
membranes, blocked with 10% skimmed milk and incubated with the
following primary antibodies overnight at 4 °C: a-tubulin, acetylated
a-tubulin, g-tubulin, GAPDH (Sigma-Aldrich) and b-actin (Santa
Cruz Biotechnology). Membranes were washed, incubated with a
horseradish peroxidase (HRP)-conjugated secondary antibody, and
visualized using a chemiluminescent detection reagent kit (Thermo-
Fisher Scientific).
Statistics
Descriptive results were expressed as mean § standard deviation
(SD) or mean § error of the mean (SEM), as appropriate. Spearman
bivariate correlations were performed for all quantitative variables
and differences between groups were compared using analysis of vari-
ance (MannWhitney U or KruskalWallis analysis of variance, as
appropriate).The analysis for all quantitative variables and differences
between groups were compared using analysis of variance (U-Mann
Whitney or Kruskal Wallis ANOVA, as appropriate). Samples from all
groups within an experiment were processed at the same time. The
p-values were two sided and statistical significance was considered
when p < 0.05. Data is presented with the specific p-values: p < 0.05,
p < 0.01, p < 0.005 and p < 0.001. All statistical analyses were per-
formed using STATA 12.0 and GraphPad Prism 4 software.
Data availability
The authors declare that the data supporting the findings of this
study are available within the article and its Supplementary Informa-
tion files, or are available in a persistent repository or upon reason-
able requests to the authors.
Next generation sequencing data supporting the findings of this study
are deposited in Bioproject: PRJNA396505 and PRJNA530166 and Bio-
samples: SAMN07427434, SAMN07427435, SAMN07427436,
SAMN07427437, SAMN07427438, SAMN07427439, SAMN07427440,
SAMN07427441, SAMN07427442, SAMN07427443, SAMN07427444,
SAMN07427445, SAMN07427446, SAMN07427447, SAMN07427448,
SAMN07427449, SAMN07427450, SAMN07427451 and SAMN07427452.
Results
Integrated miRNA and mRNA profiling reveals cilia related genes in AITD
pathophysiology
Analysis of miRNA and mRNA samples of AITD vs. control samples
identified 19 deregulated miRNAs and 3690 deregulated genes. As
reported previously [11], control samples formed a separate sub-
cluster from AITD samples. However, the analysis revealed a slightly
but not substantial separation between AITD groups. We, therefore,
Fig. 1. (a) Visualization of a subnetwork of the miRNAmRNA anti-correlation and of the involved Gene Ontology (GO) biological processes. MiRNAs are represented in red, genes in
green and biological processes in blue. (b) Pie representation of the top ten biological processes generated in the miRNAmRNA analysis. (c) Comparison of the relative expression
of the miRNAs involved in the subnetwork between 10 controls and 26 AITD thyroid tissues: miR-21-5p, miR146b-3p, miR-5571-3p and miR-6503-3p were upregulated in AITD
compared to controls. (d) Validation by qPCR of the expression of the downregulated genes ENO4, INTU, KIF27, PACRG and STK36 in 39 AITD and 11 controls thyroid tissues. Data
are presented as mean +/- standard deviation relative expression: *p < 0.05; **p < 0.01; ns=not significant (by MannWhitney test or by two sided unpaired t-test as appropriate).
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samples together in the same group, in comparison with the control
group (Supplementary Fig. 1).
We then examined the expression of miRNAs that negatively cor-
related with the expression levels of their target genes. We found a
specific anti-correlation of 17 miRNAs and 160 genes. The interac-
tions were visualized as a network using Cytoscape (Fig. 1a), which
revealed a high number of genes related with ciliary organization
(Fig. 1b). The most represented anti-correlated miRNAs and genes
were: miR-21-5p, miR-146b-3p, miR-5571-3p and miR-6503-3p and
ENO4 (Enolase 4), INTU (in-turned planar cell polarity protein), KIF27
(kinesin family member 27), PACRG (parkin co-regulated) and STK36
(serine/threonine kinase 36). These findings were validated by qPCR,
and revealed an upregulation of miR-21-5p, miR-146b-3p, miR-
5571-3p (p < 0.01; p < 0.001 and p < 0.05 respectively, by Man-
nWhitney test), and miR-6503-3p, which did not reach significance
(Fig. 1c). Conversely, their target genes were significantly downregu-
lated: ENO4 (p < 0.01, by Mann-Whitney test), INTU (p < 0.01, by
Mann-Whitney test), KIF27 (it did not reach significance), PACRG (p
< 0.01, by Mann-Whitney test) and STK36 (p < 0.05, by two sided
unpaired t-test) (Fig. 1d).
To assess the existence of any possible associations between
miRNA and mRNA levels and clinical features we investigated the
correlations of all the analyzed miRNAs and genes with patients’ cor-
responding serum levels of free thyroxine (T4), thyrotropin (TSH),
antithyroid peroxidase antibody (TPO-Ab), antithyroglobulin anti-
body (Tg-Ab), and TSHR-Ab (correlation heatmaps in Supplementary
Fig. 2). Spearman r analyses revealed that miR-146b-3p was posi-
tively associated with levels of Tg-Ab (r = 0.52 and p = 0.048), miR-
6503-3p positively correlated with levels of TSHR-Ab (r = 0.56 and
p = 0.02), however was negatively associated with T4 levels (r =0.62
and p = 0.0086). We therefore associated clinical data with mRNAlevels, however, any of the genes analyzed correlated with clinical
features (Supplementary Fig. 2).
Decreased number and length of cilia in AITD tissues
To identify primary cilia, we used acetylated a-tubulin at K40 and
ADP ribosylation factor like GTPase 13B (Arl13B), which localize to
the cilia [21]. Fig. 2a and b show control thyroid glands comprised by
follicular cells with a primary cilium that extend from the apical sur-
face of each thyrocyte towards the colloid-rich follicular lumen. Five
cases with nodular hyperplasia were also quantified and no remark-
able changes in cilia frequency with control thyroids were found
(Supplementary Fig. 3). The frequency of follicular ciliated cells in
control thyroid tissue was of 67.54% (of a total count of 5796 nuclei).
In thyroid tissue from HT and GD patients (Fig. 2cf), however, the
presence of primary cilia was significantly reduced, with a mean of
22.74% ciliated cells in HT and 21.61% in GD (of a total count of 7902
and 6492 nuclei, respectively) (p < 0.0001, by one-way ANOVA test)
(Fig. 2g). We also examined ciliary length and observed significantly
shorter primary cilia in both HT and GD, compared to controls (aver-
age length 4.85 § 2.13; 3.93 § 2.3 and 3.02 § 2.3, respectively;
p< 0.0001, by KruskalWallis test) (Fig. 2h and i). To determine if cil-
iary defects were associated with acetylation defects in thyroid tis-
sue, we measured the acetylation of a-tubulin at K40 in tissue
extracts and found no statistically significant differences between tis-
sue samples (Supplementary Fig. 4).
To further characterize cilia structures and elucidate differences in
their architecture, we used stimulated emission depletion (STED)
microscopy. As observed in the 3D reconstruction of follicles, the
number of cilia was reduced in HT and GD (Fig. 3a). Quantification of
the mean intensity of the cilia along its length (ROI; region of inter-
est) allowed the projection of its mean intensity of fluorescence per
Fig. 2. (af) Representative images captured by confocal microscopy characterizing the primary cilia of controls (a and b), HT (c and d) and GD (e and f) thyroid follicles stained with
acetylated a-tubulin (in green) and Arl13b (in red). In controls, primary cilia usually appear as one cilium per thyrocyte; however in HT and GD thyroid tissues, primary cilia exhib-
ited a shorter length and some cells even lacked this structure (g). Quantification of primary cilia in a total of 5796 nuclei of 41 confocal images in control tissue, 7902 nucluei in
70 images captured in HT tissue and 6492 nuclei in 54 images of GD thyroid samples. Control samples had higher ciliated cells compared to HT and GD (****p < 0. 0001; by one-way
ANOVA test). (h) Length quantification of a total of 3900 cilia (1300 cilia per group), as observed in the column graph, HT and GD presented shorter cilia compared to controls
(****p < 0.0001, by KruskalWallis test). (i) Histogram representing the frequency distribution of cilia length in the three groups. In HT and GD the distribution of cilia length over-
laps around 03mm, with the GD group having the shorter cilia length values. Control samples portrayed higher length values, around 45mm.
334 R. Martínez-Hernandez et al. / EBioMedicine 50 (2019) 329342pixel (MFI) profile. The distribution and expression of the pixel count
in controls was significantly different from that observed in AITD
(Fig. 3b and c). Cilia profiles from control samples showed that both
fluorochromes, Arl13b and acetylated K40 a-tubulin, overlapped
towards the ROI (maximum intensity of 200 AU, length 6 mm),
whereas acetyl-K40 a-tubulin appeared severely reduced (maximumintensity below 80 AU and a length <2 mm) in HT and GD samples.
Interestingly, the profile distribution was different in HT and GD;
whilst HT fluorescence spectrum of both markers coincides along the
cilium, the GD profile showed a cluster of acetyl-K40 a-tubulin at the
proximal part of the cilium, which decreased as Arl13b fluorescence
intensified until the distal tip.
Fig. 3. (a) Representative 3D reconstructions from Confocal stacks of thyroid follicles from control, HT and GD patients. Magnifications from insets (white squares) correspond to 3D
projections of volume segmentations from cilia structures imaged with STED confocal (xy optimized). Imaris was used to generate the 3D volumes and segmentation (surfaces). Sur-
faces represent the intensity of fluorescence detected for the analyzed fluorochromes (Red, anti-Arl13b plus alexa-568-conjugated anti-rabbit antibody; Green, anti-Acetylated-K40
a-Tubulin plus alexa-488-conjugated anti-mouse antibody). (b) Profiles of the mean intensity of fluorescence per pixel (MFI) of representative cilia from samples of healthy controls,
GD and HT patients. Red, MFI of Arl13b; Green, Acetylated-K40 a-tubulin. (c) Quantification of the MFI showed that Arl13b and acetylated a-tubulin are significantly reduced in HT
and GD samples (****p < 0.0001; by KruskalWallis test).
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ther morphological details of cilia defects in both HT and GD samples
(Fig. 4). In control samples follicular cells displayed a polyhedraloutline averaging 6 sides, and one or two cilia were present in the
center of the cell’s follicular surface. In addition, the cell surface had
unevenly distributed microvilli, which tended to concentrate along
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without ciliary pocket, and the morphology of the ciliary base resem-
bled the arrangement described for the appendages of the basal body
(Fig. 4d) [22]. AITD samples contained thyroid cells of different sizes,
with irregularly outlined polyhedral sides, from which cilia emerged
as vestigial structures from the center. In HT, follicular cells had dif-
ferent shapes with irregular margins, which sometimes even jeopar-
dized the distinction between cells (Fig. 4fj). Hypomorphic cilia
emerged from the center of each cell, sometimes appearing as “vol-
cano-like” structures (Fig. 4j). In GD, follicular cells displayed a con-
vex surface filled with microvilli; and short, microvilli-like cilia were
also occasionally observed at the center of the cell (Fig. 4ko).
Inflammatory cytokines decreased primary cilia appearance in thyroid
cell cultures
Combination of IFN-g with TNF-a in thyroid follicular cell cultures
mimic the high inflammatory scenario found in AITD [20]. Stimula-
tion of the untransformed human thyroid follicular cell line N-ThyFig. 4. High resolution SEM images from control (ae), HT (fj) and GD (ko) thyroid gland
with, normally, 5 or 6 sides. In the center of the cell, a long primary cilium is usually observe
face of the cell, which concentrates at the cell border, shaping epithelial cells. In HT (fj), f
short cilia with different shapes and sizes were present in the center of each cell remindin
microvilli. Shortened cilia were also seen at the center of the cell. An example of two small ciOri with pro-inflammatory cytokines in serum-starved medium sig-
nificantly reduced ciliogenesis (Fig. 5ae; p < 0.005, by two sided
unpaired t-test). Interestingly, the length of the scarce cilia in treated
thyroid cells was increased in comparison to those in the normal
(Basal) condition (mean of 7.2 mm vs mean of 4.5 mm, respectively,
Fig. 5f and g; p < 0.005, by MannWhitney test). Performing a timing
of ciliogenesis at basal and proinflammatory conditions, we observed
at basal conditions a moderate increase of the percentage of cilia as
time goes by. However after CK treatment, the highest percentage of
ciliogenesis was reached at 24 h and then decreased, suggesting a
fragile behavior of cilia in proinflammatory cultures (Fig. 6). Notably,
acetyl-K40 a-tubulin was similar in total extracts from stimulated vs.
non-stimulated cells (Fig. 5h and i). To assess expression differences
of the ciliary-related genes observed in the miRNAmRNA correla-
tion study, we determined the expression of ENO4, INTU, KIF27,
PACRG and STK36 in both conditions. Quantitative analysis indicated
a marked increase of all ciliary genes in the presence of inflammatory
cytokines (Fig. 5j: ENO p < 0.05, by two-sided unpaired t-test; INTU
p < 0.05, by two-sided unpaired t-test; KIF27 p < 0.001, by. (a) At lower magnification, thyrocytes in normal thyroid appeared as polyhedral cells
d. (be) At higher magnification, the distributed microvilli can be observed in the sur-
ollicular cells presented different shapes and with few microvilli in their surface. Very
g stumped-cilia. (ko) In GD, follicular cells showed a convex surface with abundant
lia is shown in o.
Fig. 5. Primary cilia in NThyOri cell line cultured at basal (without cytokines) and at proinflammatory (CK: with TNF-a and IFN-g) serum starved conditions. (a and b) Immunofluo-
rescent staining of acetylated a-tubulin (green) and Arl13b (red) at basal conditions showed a higher percentage of ciliated cells (arrows) compared with those presented in CK (c
and d). (e) The frequency of ciliated cells were statistically significantly between both conditions. (f and g) Average and frequency distribution of the length in the medium with and
without cytokines. (h and i) Quantification and western blot of acetylated a-tubulin in protein cell extractions. (j) Relative expression of ciliary genes at basal and CK conditions:
ENO4, INTU, KIF27, PACRG and STK36. Data are represented as mean § SD (*p < 0.05; **p < 0.01, ***p < 0.005 and ns=not significant; by two sided unpaired t-test or by
MannWhitney test as appropriate).
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unpaired t-test). This finding indicates that stimulation of thyrocytes
with TNFa and IFNg affects ciliary formation, suggesting that cilia
assembly is affected by the pro-inflammatory environment.
miRNAs transfection affects ciliary growth in thyrocytes
To analyze the role of miRNAs in thyroid cultures we transfected N
Thy Ori cells with a negative control miRNA mimic (Negative) and a
pool of miR-146b-3p, miR-21-5p and miR-6503-3p miRNA mimics
(miRNAs Pool) (Supplementary Fig. 5). As observed in Fig. 7, in basal
conditions, miRNAs transfection (miRNAs Pool) triggered a reduction
from 57.33% to 32.78% ciliated cells (p < 0.0001, by two-sided
unpaired t-test) (Fig. 7ae). However, cilia elongation was not affected
in these conditions (Fig. 7f and g). In any case, comparison of the
expression levels of ciliary implicated genes between negative andtransfected cells demonstrated a significantly reduction of ENO4 (p <
0.001, by two-sided unpaired t-test), KIF27 (p < 0.005, by two-sided
unpaired t-test), STK36 (p < 0.0001, by two-sided unpaired t-test);
INTU and PACRG had a moderate reduction of expression, although it
did not reach significant differences (Fig. 7h). Thus, miRNA mimics
dysregulated the expression of these target genes at basal conditions,
producing an imbalance in ciliary growth in culture thyrocytes.
When we stimulated thyrocytes with TNFa and IFNg (CK) concom-
itantly with miRNA mimics (Fig. 7il), the percentage of ciliated cells
remained similar, but with a reduction in length from 5.2 mm to
4.2 mm (p < 0.05, by MannWhitney test) (Fig. 7mo). Furthermore,
expression of ENO4, KIF27, INTU and PACRG decreased significantly in
a higher proportion than in basal conditions (Fig. 7p), suggesting a syn-
ergistic effect of cytokines and miRNAs in the ciliary process. Quantifi-
cation of acetylated a-tubulin protein in cell extracts between
conditions did not reveal significant differences (Supplementary Fig. 4).
Fig. 6. Timing of ciliogenesis (at 3, 6, 24, 36 and 48 h) in arrested basal conditions and after TNFa and IFNg treatment (CK conditions). (a) Representative confocal images of cilia at both
conditions (Arl13b in red, Scale bar = 5mm) and quantification of length and percentage of cilia. (b) Frequency distribution histograms of the length of cilia during the timing experiment.
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In this study, we have identified novel molecular AITD susceptibil-
ity pathways using an integrated analysis of miRNAs and mRNAs
expression profiling of thyroid tissues from AITD patients and con-
trols. Our results revealed that mechanisms involved in ciliary devel-
opment are significantly deregulated in AITD. In addition, we have
demonstrated that genes involved in ciliary pathways (ENO4, INTU,
KIF27, PACRG and STK36) are downregulated in thyroid tissue of
AITD patients, and that the percentage of follicular ciliated cells and
cilia length are markedly reduced in HT and GD patients (Fig. 8). Fur-
thermore, we have shown that thyrocytes cultured in pro-inflamma-
tory conditions and transfected with miRNA mimics, exhibit
impaired ciliary phenotypes, indicating that ciliogenesis plays an
important role in the development of AITD.
Primary cilia typically appear alone as a single cilium in human
thyroid follicular cells. The relationship between these structures and
the Golgi apparatus suggests that cilium may act as sensory regula-
tors in the thyroid to modulate hormone secretion [14]. Indeed, trace
amine-associated receptor 1 (Taar1), a G-protein-coupled receptor,
have been described to be present in primary cilium of thyroid rodent
cells and has been attributed to function in thyroid hormones libera-
tion, thyroid autoregulation and homeostatic thyroid stimulating
hormone receptor maintenance [23,24]. Alterations of primary cilia
have also been associated in the regulation of cancer development
towards the control of metabolic phenotypes [25,26]. Lee et al. have
described defective ciliogenesis in thyroid H€urthle cell lesions associ-
ated with mitophagy or autophagy [19]. Their findings circumscribe
ciliary defects to H€urthle cells found in HT, although we observed a
generalized effect throughout the tissue. Our findings in GD however,
are consistent with a recent report in the literature which also
described decreased ciliary frequencies and cilia length in GD [16].
However, in the contrary with these authors, we did not find any dif-
ferences in cilia frequency in nodular hyperplasia, as has been previ-
ously reported by others [19]. Although these variable findings could
be attributed to thyroid tissue heterogeneity [16], they could also be
related to some degree of inflammation and/or autoimmunity that
could have been overlooked in the pathological diagnosis.MiRNAs identified herein (miR-21-5p, miR-146b-3p, miR-5571-
3p and miR-6503-3p) target genes involved in the different ciliary
processes. One such gene is INTU, which is part of the CPLANE com-
plex (Ciliogenesis and Planar Polarity Effector), which is an important
physical and functional unit governing the recruitment of microtu-
bule-based intraflagellar transport proteins to the base of cilia.
Indeed, mutation of CPLANE genes elicits specific ciliopathy pheno-
types in mouse models and it is associated with novel ciliopathies in
human patients [27]. The parkin-co-regulated gene (PACRG) and
Enolase 4 (ENO4) appear in the flagella of various eukaryotes. PACRG
directly associates with microtubules and tubulin dimers and is
involved in doublet microtubule assembly, being crucial for the sta-
bility and function of primary cilia [2830]. It is therefore conceiv-
able that downregulation of these proteins in AITD patients affects
the stability of cilia in thyroid cells, and contributes to the
impairment of ciliary growth in thyroid. Finally, STK36 encodes a ser-
ine/threonine kinase that enhances the activity of Gli transcription
factors, targeting the Hedgehog signaling pathway, which is involved
in cilia formation [31,32]. Interestingly, STK36 has been associated
with kinesin Kif27 (kinesin family member 27), which was also
downregulated in AITD samples. Both proteins are involved in the
recruitment and/or activation of central pair proteins along the cil-
ium [33], thus abnormalities in these proteins could be associated
with a defective cilia elongation in AITD. Using high resolution
microscopy techniques we have also found that the expression pro-
file of a-acetylated tubulin and Arl13b distribution between HT and
GD are somewhat different. In SEM images, stumped-cilia appeared
at the center of thyroid cells in both diseases. However in HT, several
“volcano-like” cilia were observed with a hole in the center which, as
far as we know, has never been described before.
The AITD microenvironment is clearly pro-inflammatory, indeed,
several studies have shown the importance of cytokines and chemo-
kines in its pathogenesis [34]. In this context, it was pertinent to
prove if inflammatory cytokines affected cilia formation. We found
that pro-inflammatory cytokines IFN-g and TNF-a decreased the
number of cilia despite increasing the expression of the aforemen-
tioned genes. Importantly, addition of miRNA to the system further
decreased the number of cilia and repressed the expression of the
Fig. 7. Primary cilia in NThyOri cell line cultured at basal (a-h) or with CK (io) -serum starved conditions transfected with a pool of miR-21-5p, miR-146b-3p and miR-6503-3p
mimics. (ad and il) Immunofluorescence staining of acetylated a-tubulin (green) and Arl13b (red) in negative and in pool transfected (miRNAs pool) cells. (eg and mo) Per-
centage, average length and frequency distribution of the length of ciliated cells in negative and transfected cells. (h and p) Quantification of ciliary related genes presented as rela-
tive expression. Data are represented as mean § SD (**p < 0.01, ***p < 0.005, ****p < 0.001 and ns = not significant; by two sided unpaired t-test or by MannWhitney test as
appropriate).
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Fig. 8. Proposed model of the mechanisms underlying the ciliary defects in AITD. Abnormal antigen presentation in thyroid and breakdown of tolerance to self-antigens lead to
complex and interrelated intrathyroidal immune processes. For instance, thyroid-specific B and T cells produce inflammatory cytokines such as IFNg and TNFa. This pro-inflamma-
tory environment may increase the expression of miRNAs (miR-21-5p, miR-146b-3p and miR-6503-3p). The combination of both the pro-inflammatory environment and increased
miRNA expression may repress the expression of ciliary related genes, leading to an impairment of ciliogenesis.
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onciled by the fragile behavior of cilia and the possible effect of pro-
inflammatory cytokines on the expression of cilia-related genes at a
transcriptional level. In short, those cilia that overcome the constric-
tion imposed by the pro-inflammatory conditions would be longer as
a consequence of the increased expression of the pro-cilia genes trig-
gered by cytokines. However, the fragile phenotype of these elon-
gated cilia would, in time, curtail or break their axoneme which is
consistent with an overall decrease in the number of cilia in these
cultures. Indeed, previous reports have described the elongation of
cilia in response of IL-1 via a protein kinase A dependent mechanism,
suggesting a fundamental importance of inflammation in the regula-
tion of cilia structure and function [35]. It is also important that the
combination of cytokines with miRNA, which is likely a better repre-
sentation of the actual microenvironment of thyroid during the onset
of the disease, displayed less and shorter cilia, consistent with a
miRNA-dependent repression of the cilia-related genes that is notcompensated by the pro-inflammatory cytokines. Several studies
have described the linkage between miRNA expression and cytokine
activities in two complementary ways: from a regulation of the
expression and secretion of miRNAs by cytokines and vice versa, a
regulation of cytokine expression by miRNAs [36,37]. Interestingly,
miR-21 controls the production of pro-inflammatory cytokines in
TGF-b receptor II mutant mice, contributing in the development of
autoimmune cholangitis and colitis [37].
Together, data herein strongly support that cilia deregulation in
thyroid cells is part of the molecular mechanism that underlies AITD.
This is likely related to the normal function of primary cilia in this tis-
sue. Primary cilia activate a wide range of responses and numerous
intracellular signal transduction cascades essential for cell develop-
ment, proliferation, differentiation, survival and migration. Major sig-
naling routes influenced by primary cilia include Hedgehog, platelet-
derived growth factor (PDGF)-a signaling, and cell polarity Wnt path-
ways, as well as the insulin growth factor (IGF-1)-receptor signaling
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AITD, for example Graves’ Orbitopathy [22,3841]. In fact, the TSHR
and IGF-1R pathways form a functional complex in thyroid and
orbital tissue [41] that is involved in the recruitment of T cells to the
affected organs during the onset of GD [40].
This research, however, is subject to some limitations. MiRNA and
mRNA NGS were performed in whole thyroid tissue, thus, it was diffi-
cult to differentiate the roles of infiltrating lymphocytes and thyro-
cytes. In addition, although we did not observe any statistical
correlations between thyroid hormone levels and gene expression,
whether thyroid dysfunction could also had a role in ciliogenesis
should be address in further studies.
To conclude, it is important to emphasize that novel molecular
approaches, as the integration of heterogeneous types of omics data
like the miRNAmRNA network, have the potential to identify new
molecular susceptibility pathways. This contributes to the develop-
ment of new therapeutic approaches, e.g. targeting miRNAs, to treat
inflammatory conditions such as AITD or other autoimmune diseases.
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